NATERA, INC. Net Income (Loss) Available to Common Stockholders, Diluted
NATERA, INC. (NTRA) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$124.83 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2020-03-02
- NATERA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2018-03-31 was -$32.87M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2017-03-31 was -$34.52M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2015-12-31 was -$22.96M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2015-09-30 was -$17.63M, a 1604.27% decline year-over-year.
- NATERA, INC. net income (loss) available to common stockholders, diluted for fiscal 2019 was -$124.83M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for fiscal 2018 was -$128.15M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for fiscal 2017 was -$138.78M.
- NATERA, INC. net income (loss) available to common stockholders, diluted for fiscal 2016 was -$100.33M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | -$124.83M 10-K · filed 2020-03-02 | ||||
| 2018-12-31 | -$128.15M 10-K · filed 2020-03-02 | ||||
| 2018-03-31 | -$32.87M 10-Q · filed 2018-05-10 | ||||
| 2017-12-31 | -$138.78M 10-K · filed 2020-03-02 | -$137.46M 10-K · filed 2018-03-15 | |||
| 2017-03-31 | -$34.52M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | -$100.33M 10-K · filed 2019-03-15 | -$95.77M 10-K · filed 2018-03-15 | |||
| 2015-12-31 | -$22.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$40.59M derived: sum of 2 quarters · filed 2018-03-15 | -$70.28M 10-K · filed 2018-03-15 | ||
| 2015-09-30 | -$17.63M 10-Q · filed 2015-11-13 | -$47.31M 10-Q · filed 2015-11-13 | |||
| 2014-09-30 | $1.17M 10-Q · filed 2015-11-13 | -$6.41M 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |